In the realm of antimicrobials, macrolides stand out as a versatile class of antibiotics with a broad spectrum of activity. These drugs are characterized by their complex structure, consisting of a large macrocyclic lactone ring. This unique structure contributes to their ability to combat a diverse range of bacterial infections. Erythromycin, the prototypical macrolide, paved the way for subsequent derivatives like azithromycin and clarithromycin. Their mechanism of action involves binding to the bacterial ribosome, inhibiting protein synthesis. This interference disrupts the normal functioning of bacteria, leading to their inhibition or destruction. Macrolides find application in the treatment of respiratory tract infections, skin and soft tissue infections, and certain atypical bacterial infections. Azithromycin, in particular, is well-regarded for its wide tissue distribution and prolonged action, allowing for shorter treatment courses. While macrolides are generally well-tolerated, they are not immune to adverse effects. Gastrointestinal symptoms, liver enzyme abnormalities, and potential interactions with other medications should be considered when prescribing these antibiotics. As with any antimicrobial, prudent use and awareness of potential side effects are crucial for optimizing patient outcomes.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : A rare case of meningitis and septicemia due to Streptococcus acidominimus
Percival C Dilla, Region II Trauma and Medical Center, Philippines
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Association between cardiometabolic risk factors and COVID-19 severity in patients of a rural tertiary hospital
Percival C Dilla, Region II Trauma and Medical Center, Philippines